BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18396752)

  • 1. The metabolic syndrome and the liver.
    Verrijken A; Francque S; Van Gaal L
    Acta Gastroenterol Belg; 2008; 71(1):48-59. PubMed ID: 18396752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
    Rahimi RS; Landaverde C
    Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome and nonalcoholic fatty liver disease.
    Collantes RS; Ong JP; Younossi ZM
    Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of liver disease in Korea: nonalcoholic fatty liver disease.
    Park SH
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S34-9. PubMed ID: 20037278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome.
    Moscatiello S; Di Luzio R; Sasdelli AS; Marchesini G
    Expert Opin Pharmacother; 2011 Dec; 12(17):2657-72. PubMed ID: 22043839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver: a novel component of the metabolic syndrome.
    Kotronen A; Yki-Järvinen H
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of metabolic syndrome in children and adolescents.
    Pacifico L; Anania C; Martino F; Poggiogalle E; Chiarelli F; Arca M; Chiesa C
    Nutr Metab Cardiovasc Dis; 2011 Jun; 21(6):455-66. PubMed ID: 21565479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diets and nonalcoholic fatty liver disease: the good and the bad.
    Asrih M; Jornayvaz FR
    Clin Nutr; 2014 Apr; 33(2):186-90. PubMed ID: 24262589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Perseghin G
    Dig Dis; 2010; 28(1):210-3. PubMed ID: 20460913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and cardiovascular disease.
    Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
    Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of the metabolic syndrome in the USA.
    McCullough AJ
    J Dig Dis; 2011 Oct; 12(5):333-40. PubMed ID: 21091931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the metabolic syndrome to NAFLD or vice versa?
    Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
    Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.